Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 1781-1788, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galli, F.
Right arrow Articles by Canestrari, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galli, F.
Right arrow Articles by Canestrari, F.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1999;45:1781-1788.)
© 1999 American Association for Clinical Chemistry, Inc.


Articles

Overexpression of Erythrocyte Glutathione S-Transferase in Uremia and Dialysis

Francesco Galli1,a, Simona Rovidati1, Serena Benedetti1, Umberto Buoncristiani2, Carla Covarelli2, Ardesio Floridi3 and Franco Canestrari1

1 "G. Fornaini" Institute of Biological Chemistry, University of Urbino, 2-61029 Urbino, Italy.

2 Nephrology and Dialysis Unit, "R. Silvestrini" Hospital, 06100 Perugia, Italy.

3 Department of Molecular and Cellular Biology, University of Perugia, 06100 Perugia, Italy.
a Address correspondence to this author at: Istituto di Chimica Biologica "G. Fornaini", Via Saffi, 2-61029 Urbino (Ps), Italy. Fax 39-722-320188; e-mail galli{at}uniurb.it

Background: Overexpression of glutathione S-transferase (GST; EC 2.5.1.18) has been documented in the erythrocytes of patients with chronic renal failure, and this event may well be of relevance from a clinical standpoint. In fact, it could serve as a marker of uremic toxicity overall, which can contribute to impair the function and survival of the erythrocytes. However, the biochemical details of this phenomenon are poorly understood.

Methods: In this study, we characterized the expression of GST in erythrocytes of 118 uremic patients under different clinical conditions. The mechanisms responsible for the regulation of protein expression and enzyme activity were investigated in light of different dialysis approaches, oxidative stress, uremic toxins, erythrocyte age, and erythropoietin (EPO) supplementation.

Results: Mean GST activity in uremic patients was highly overexpressed with respect to controls, and this phenomenon was exclusively attributable to an increased expression of GST. Overexpression of GST did not appear to be dependent on oxidative stress and was not influenced by vitamin E supplementation. In the same manner, both erythrocyte age and EPO supplementation apparently did not interfere with the GST concentrations, which were the same in controls and patients. Preliminary experiments suggested that high-molecular weight or protein-bound toxins could play some role in the overexpression of GST.

Conclusions: GST expression may be a useful marker for the individual accumulation of uremic toxins as well as of the efficiency of new dialysis strategies in removing them.




The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
F. Santangelo, V. Witko-Sarsat, T. Drueke, and B. Descamps-Latscha
Restoring glutathione as a therapeutic strategy in chronic kidney disease
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1951 - 1955.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Floridi, F. Antolini, F. Galli, R. M. Fagugli, E. Floridi, and U. Buoncristiani
Daily haemodialysis improves indices of protein glycation
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Klemm, C. Voigt, M. Friedrich, R. Funfstuck, H. Sperschneider, E.-G. Jager, and G. Stein
Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance
Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2166 - 2171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.